LipoScience (LPDX -10.7%) plummets as CEO Richard Brajer steps down "to pursue other interests."
Robert Greczyn is named interim CEO.
The company says Q2 revenues will likely come in at $13.3M, towards the low end of guidance. Consensus is $13.6M
For the full year, the company cuts its revenue guidance to $52-54M, down from $54-56M, and below Street estimates of $55.37M. (PR)